Drug-labels.com

Vyzulta: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.024 %
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Vyzulta

What is VYZULTA™ used for?

VYZULTATM is used to reduce the high pressure in the eye in patients with the following conditions:

  • open-angle glaucoma or ocular hypertension.

How does VYZULTA™ work?

VYZULTATM lowers the pressure in the eye by increasing the outflow of fluid from inside the eye.

What are the ingredients in VYZULTA™?

Medicinal ingredient: Latanoprostene Bunod

Non-medicinal ingredients: Benzalkonium Chloride (as preservative), Citric Acid, EDTA, Glycerin, Polysorbate 80, Sodium Citrate and Water.

VYZULTA™ comes in the following dosage form:

As an ophthalmic solution (eye drops) containing 0.24 % w/v of latanoprostene bunod (0.24 mg/mL). Available in 7.5 mL bottle with a 5 mL fill volume.

Do not use VYZULTA™ if you:

  • are allergic to latanoprostene bunod
  • are allergic to any of the other ingredients in VYZULTATM or to a component of the container.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take VYZULTA™. Talk about any health conditions or problems you may have, including if you:

  • have or have had eye inflammation including the conditions iritis or uveitis.
  • have or have had a torn posterior lens capsule.
  • have or have had eye swelling including a condition called macular edema.
  • have or have had a viral infection of the eye called herpes keratitis.
  • have severe asthma or asthma that is not controlled.
  • are using any other eye drops.
  • notice any changes in your eyelashes or color of your eyes.
  • wear contact lenses.
  • tare pregnant or planning to become pregnant

  • are breast feeding or planning to breastfeed.

Other warnings you should know about:

Driving and using machines

Wait until you can see clearly before driving or operating machines after applying VYZULTATM.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take VYZULTA™:

  • Apply one drop of VYZULTATM into each affected eye
  • Be careful not to touch your eye, eyelids, surrounding areas, fingers or any other surface with the dropper tip of the bottle. If you do, you may contaminate the medicine and this can cause you to have an eye infection. Avoid touching the tip of the bottle.
  • If you wear contact lenses, remove them before applying VYZULTATM. You may reinsert them 15 minutes after you have applied VYZULTATM.
  • If your doctor has prescribed other eye drops to be taken along with VYZULTATM, apply each medicine at least 5 minutes apart.
  • Use VYZULTATM exactly as your doctor has told you to. Do not apply VYZULTATM more than once a day.

Usual dose:

The recommended dose of VYZULTATM is one drop into the affected eye(s) once daily in the evening.

Overdose:

If you think you have taken too much VYZULTA™, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you forget to use VYZULTATM, continue your treatment with the next dose the following day.

What are possible side effects from using VYZULTA™?

These are not all the possible side affects you may feel when taking VYZULTA™. If you experience any side effects not listed here, contact your healthcare professional.

Side effects may include:

Common:

  • eye irritation
  • eye redness
  • eye pain
  • pain in your eye at the application site
  • runny or stuffed nose, sore throat

Rare:

  • altered sense of taste
  • feeling of grittiness or having something in the eye

VYZULTATM may change colour of your eye or eyelid. The eye color change may not be noticeable for many months to years. The eye color and eyelid changes may be permanent. Tell your doctor if your eye color has changed. They may examine your eyes more often.

VYZULTATM may also cause your eye lashes to appear thicker and longer than they usually do and increase in number. Eyelash changes are reversible after treatment with VYZULTATM is stopped.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

RARE

Bacterial keratitis (infection of the eye): eye pain or redness, decreased vision, discharge from the eye, sensitivity of the eye to light, swelling of the eye or eyelid, watery eyes or production of tears.

X
Macular edema swelling and build-up of fluid in the center of the retina): blurry vision, blurry or wavy vision near or in the center of your field of vision, colors may appear washed out or faded.X

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Before VYZULTATM is first opened, keep it in a fridge (between 2°C and 8°C). Once the bottle has been opened, VYZULTATM may be kept at room temperature up to 25°C. Discard the bottle and/or unused contents after 8 weeks. VYZULTATM should not be used after the expiry date on the bottle. Protect from light. Protect from freezing.

Keep out of reach and sight of children.

If you want more information about VYZULTA™:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/index-eng.php) or by calling 1-800-361-4261.

VYZULTA™ is a trademark of Bausch & Lomb Incorporated or its affiliates.

Last Revised: December 27, 2018

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02484218

Revision date stated in the text: December 27, 2018

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Vyzulta

Rx or OTC
Prescription (Rx)?
DIN 02484218
Schedule(s) PRESCRIPTION
Active ingredient(s) Latanoprostene bunod 0.024 %
Dosage form(s) Solution
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01E Antiglaucoma preparations and miotics
        1. S01EE Prostaglandin analogues, antiglaucoma drugs and miotics
          1. S01EE06 Latanoprostene bunod
Company BAUSCH & LOMB INC
Current status Marketed
Current status date May 17, 2019

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.